Approvals/CIMA-AEMPS/SOLIFENACINA/TAMSULOSINA ALTER 6 MG/0,4 MG COMPRIMIDOS DE LIBERACIÓN MODIFICADA EFG

Approved

STANDARD

SOLIFENACINA/TAMSULOSINA ALTER 6 MG/0,4 MG COMPRIMIDOS DE LIBERACIÓN MODIFICADA EFG

Laboratorios Alter S.A.🇪🇸 Spanish Agency of Medicines and Medical Devices

Approval Id: 67aa0c49d0072bd5
Drug Cima Aemps Name: SOLIFENACINA/TAMSULOSINA ALTER 6 MG/0,4 MG COMPRIMIDOS DE LIBERACIÓN MODIFICADA EFG
Register Number: 89139
Holder Company Name: Laboratorios Alter S.A.
Marketing Company Name: Laboratorios Alter S.A.
Authorization Date: 2023-11-08
Dosage Form: COMPRIMIDO DE LIBERACIÓN MODIFICADA
Dose: 6 mg /0,4 mg
Route Of Administration: VÍA ORAL
Prescription Type: Medicamento Sujeto A Prescripción Médica
Commercialized: Yes
Company Name: Laboratorios Alter S.A.

SOLIFENACINA SUCCINATO

6,00 mg

TAMSULOSINA HIDROCLORURO

0,4 mg

Approved

Agency

CIMA-AEMPS

Country

🇪🇸

Approval Date

Nov 8, 2023

Approval ID

67aa0c49d0072bd5

Type

Standard